Compounds > gemcitabine
Page last updated: 2024-08-24

gemcitabine and alovudine

gemcitabine has been researched along with alovudine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bares, R; Bartusek, G; Dittmann, H; Dohmen, BM; Kehlbach, R; Pritzkow, M; Sarbia, M1
Cass, CE; Paproski, RJ; Young, JD1
Morishita, F; Okazawa, H; Orisaka, M; Tsuyoshi, H; Yoshida, Y1
Aboagye, EO; Barwick, T; Challapalli, A; Howell, EC; Mauri, F; Maxwell, RJ; Merchant, S; Pearson, RA; Sharma, R; Sumpter, K1
Faber, C; Griffiths, JR; Heinzmann, K; Held, A; Hermann, S; Honess, DJ; Jacobs, AH; Schelhaas, S; Smith, DM; Wachsmuth, L1

Other Studies

5 other study(ies) available for gemcitabine and alovudine

ArticleYear
Early changes in [18F]FLT uptake after chemotherapy: an experimental study.
    European journal of nuclear medicine and molecular imaging, 2002, Volume: 29, Issue:11

    Topics: Antineoplastic Agents; Artifacts; Carcinoma, Squamous Cell; Cell Survival; Cisplatin; Deoxycytidine; Dideoxynucleosides; Dose-Response Relationship, Drug; Esophageal Neoplasms; Fluorodeoxyglucose F18; Fluorouracil; Gemcitabine; Humans; Methotrexate; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Tumor Cells, Cultured

2002
Predicting gemcitabine transport and toxicity in human pancreatic cancer cell lines with the positron emission tomography tracer 3'-deoxy-3'-fluorothymidine.
    Biochemical pharmacology, 2010, Feb-15, Volume: 79, Issue:4

    Topics: Biological Transport; Cell Line, Tumor; Deoxycytidine; Dideoxynucleosides; Fluorine Radioisotopes; Gemcitabine; Humans; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Protein Binding

2010
18F-fluorothymidine PET is a potential predictive imaging biomarker of the response to gemcitabine-based chemotherapeutic treatment for recurrent ovarian cancer: preliminary results in three patients.
    Clinical nuclear medicine, 2013, Volume: 38, Issue:7

    Topics: Aged; Biomarkers, Tumor; Deoxycytidine; Dideoxynucleosides; Female; Gemcitabine; Humans; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed

2013
3'-Deoxy-3'-¹⁸F-fluorothymidine positron emission tomography as an early predictor of disease progression in patients with advanced and metastatic pancreatic cancer.
    European journal of nuclear medicine and molecular imaging, 2015, Volume: 42, Issue:6

    Topics: Aged; Aged, 80 and over; Deoxycytidine; Dideoxynucleosides; Female; Gemcitabine; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed

2015
Gemcitabine Mechanism of Action Confounds Early Assessment of Treatment Response by 3'-Deoxy-3'-[18F]Fluorothymidine in Preclinical Models of Lung Cancer.
    Cancer research, 2016, 12-15, Volume: 76, Issue:24

    Topics: Animals; Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; Deoxycytidine; Dideoxynucleosides; Diffusion Magnetic Resonance Imaging; Disease Models, Animal; Female; Flow Cytometry; Gemcitabine; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Lung Neoplasms; Mice; Mice, Nude; Positron-Emission Tomography; Radiopharmaceuticals; Xenograft Model Antitumor Assays

2016